Renal Tumors Undergoing Active Surveillance Demonstrate Gompertzian Growth Kinetics
Main Category: Urology / NephrologyAlso Included In: Cancer / Oncology
Article Date: 22 Jun 2008 - 0:00 PDT
| Patient / Public: | ![]() |
4 (1 votes) |
| Healthcare Prof: | ![]() |
ORLANDO, FL (UroToday.com) - Crispen and colleagues examined growth pattern kinetics in their series of renal masses under surveillance. This report describes 161 lesions in 146 patients with a median follow up of 26 months (12 - 156 months). The tumors in the series had the following characteristics: median diameter 2.0 cm (0.4 to 12.0 cm), median volume 4.18cm3 (0.0033 - 903.74 cm3). 85% of the lesions were solid on imaging at presentation.
25% of tumors did not exhibit any growth while on the surveillance protocol. Interestingly, tumor size at presentation was not predictive for lack of growth (p>0.05). For tumors that did exhibit growth, the changes in tumor volume exhibited Gompertzian growth kinetics - smaller tumors grew faster than the larger ones.
Similar findings were reported on Sunday May 18th by the group from the National Cancer Institute in patients with von Hippel Lindau (VHL) disease.
Presented by Paul L Crispen, MD, Rosalia Viterbo, MD, David Y T Chen, MD, Richard E Greenberg, MD and Robert G Uzzo, MD, at the Annual Meeting of the American Urological Association (AUA) - May 17 - 22, 2008. Orange County Convention Center - Orlando, Florida, USA.
Reported by UroToday.com Contributing Editor Alexander Kutikov, MD
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
Copyright © 2008 - UroToday
Visit our urology / nephrology section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/112294.php>
APA
http://www.medicalnewstoday.com/releases/112294.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




